| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | protein targeting to membrane | 1.41e-03 | 149 | 8 | 2 | GO:0006612 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.03e-03 | 129 | 8 | 2 | GO:0030863 | |
| Domain | PDZ | 1.76e-03 | 151 | 8 | 2 | PS50106 | |
| Domain | PDZ | 1.78e-03 | 152 | 8 | 2 | IPR001478 | |
| Pubmed | 2.15e-05 | 31 | 8 | 2 | 19041431 | ||
| Pubmed | CIN85 interacting proteins in B cells-specific role for SHIP-1. | 6.59e-05 | 54 | 8 | 2 | 21725061 | |
| GeneFamily | PDZ domain containing | 1.43e-03 | 152 | 7 | 2 | 1220 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.15e-04 | 126 | 8 | 2 | 61e599678680e5aa86291c2b347b2995014591ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-04 | 148 | 8 | 2 | 12fa2c4922f03803006c606b1b16e79441e3bb13 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-04 | 159 | 8 | 2 | 7bb76324d2026d4bd348126cb169c8411f0d7145 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-04 | 159 | 8 | 2 | 807ee55fe0d3645fbfb98f641dd0a0555b847cf5 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-04 | 164 | 8 | 2 | df9fe446c1a43100048e11c01bf009bec3414dcf | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-04 | 164 | 8 | 2 | 43045879505774ac0d9b7f760557955564f06d00 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-04 | 164 | 8 | 2 | f5cacd7b2329cb0c7c1696eb4d8f89a4bbd9dda1 | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 165 | 8 | 2 | 941a5b95164eaea47c3e6376e358f94c15b98312 | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 165 | 8 | 2 | be7e18d798e81e4b0f3080054aa222c6913e350b | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 166 | 8 | 2 | c1f18de4a1a2b6cdc703e6d29d136e1134fcbdf3 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 166 | 8 | 2 | 94c30d6ca179d0cb02a5ed0093c5a2871e17ae50 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-04 | 167 | 8 | 2 | a54e200789db14f41c9fc8d21cd7fa7cedde77ad | |
| ToppCell | droplet-Tongue-TONGUE-1m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-04 | 167 | 8 | 2 | e85d97f8b0127663a3295db2b22b8488c0148455 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-04 | 167 | 8 | 2 | ac21c7112b592e30473e693a2bbee81ff0bb0160 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-04 | 167 | 8 | 2 | 47447bcf184b1ad24ef17e135199fe7cd1d73c02 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 168 | 8 | 2 | a4eebc78babb9b5ef33065b0642793820195a613 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-04 | 169 | 8 | 2 | ae975e982faf2f161fbba8edb919981e54d9ce17 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 171 | 8 | 2 | 5b74df72e36ad04dfb25c72f1ca8efe043f6cda6 | |
| ToppCell | facs-Heart-RA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-04 | 173 | 8 | 2 | 4fa5f502fa3ff8f888e279f68a0dafd91b37f26f | |
| ToppCell | facs-Heart-RA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-04 | 173 | 8 | 2 | ea406b47ff3ead992bc06f6b1707c76eee574782 | |
| ToppCell | facs-Heart-RA-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-04 | 173 | 8 | 2 | 5058cb5e3f2d57dbe947e1b113eb2bef7bf6dd7d | |
| ToppCell | Tuft-tuft-4|World / Class top | 4.10e-04 | 174 | 8 | 2 | d6f306ebf66061bf9e9742000bfedce12d277452 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.15e-04 | 175 | 8 | 2 | 4655d3daa95e8ffa7d5ee4180de06b2fec361bfb | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-04 | 177 | 8 | 2 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | droplet-Tongue-nan-3m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-04 | 177 | 8 | 2 | 34bd46704827c9db7053bbd0c671dd0b661b79b4 | |
| ToppCell | droplet-Tongue-nan-3m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-04 | 177 | 8 | 2 | b6c0ab701d9db3f19605b4d23f7e40adca3324e1 | |
| ToppCell | droplet-Tongue-nan-3m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-04 | 177 | 8 | 2 | 8f4b2f21091d981c12000489054198127098f62c | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-cDC2|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-04 | 178 | 8 | 2 | 32120936a524c38e621bd2fca17524fef74422e0 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.39e-04 | 180 | 8 | 2 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 4.39e-04 | 180 | 8 | 2 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Brain / Location, Cell class and cell subclass | 4.39e-04 | 180 | 8 | 2 | 51727cb66fe7a7709453f7026e0ff3d6c93d5aa5 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 182 | 8 | 2 | 0f06309318c064f0ebdb12a46226b90032290137 | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.48e-04 | 182 | 8 | 2 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.48e-04 | 182 | 8 | 2 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 182 | 8 | 2 | 9465238ac806fce46dfe1a141e83893f23eb4afb | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue | 4.53e-04 | 183 | 8 | 2 | c94ee9f35b21252e1ab5ab15b6a2ce69a7d753f7 | |
| ToppCell | Dendritic_Cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.53e-04 | 183 | 8 | 2 | 499da89b4abe7b746e703cd1e5c56f9b1d97ac3c | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 4.53e-04 | 183 | 8 | 2 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 183 | 8 | 2 | 107cc756c45d6e92181659868d91188814dae66d | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 4.53e-04 | 183 | 8 | 2 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.63e-04 | 185 | 8 | 2 | ed7b26bdebfd0df2b4f5020a855a052d94ae7219 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 4.78e-04 | 188 | 8 | 2 | 0e8ac42c439f30a05e015210e1d5c2dcb9d9d471 | |
| ToppCell | MS-mono3|MS / Condition, Cell_class and T cell subcluster | 4.78e-04 | 188 | 8 | 2 | a50a766c2f02e776c8e5c6e0833ec241c61831c4 | |
| ToppCell | MS-mono3-|MS / Condition, Cell_class and T cell subcluster | 4.78e-04 | 188 | 8 | 2 | e8c1c2941ca4919e0097a65b692b7af8018e8886 | |
| ToppCell | Dendritic_Cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.94e-04 | 191 | 8 | 2 | b51c8ff1279581088557bb36760c70209c77148c | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-H_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.99e-04 | 192 | 8 | 2 | 7a6dd2ae217b8f8e460d47ad128904408299458c | |
| ToppCell | tumor_Lung-B_lymphocytes-Follicular_B_cells|tumor_Lung / Location, Cell class and cell subclass | 5.04e-04 | 193 | 8 | 2 | d0cb4bfc11491c903cb4cc0f823dd1ee239cf5c4 | |
| ToppCell | IIH|World / Condition, Cell_class and T cell subcluster | 5.04e-04 | 193 | 8 | 2 | a9af5ccff108d51939ead130583f5b950d3092ed | |
| ToppCell | MNPs-Dendritic_Cells|MNPs / lung cells shred on cell class, cell subclass, sample id | 5.04e-04 | 193 | 8 | 2 | 0e6b8e179bfe1c6e93137c76c76a91c7782a4989 | |
| ToppCell | Dendritic_Cells|World / lung cells shred on cell class, cell subclass, sample id | 5.04e-04 | 193 | 8 | 2 | 7792eb6e247af2d7a8f80476f37dcd880922d625 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 5.04e-04 | 193 | 8 | 2 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.09e-04 | 194 | 8 | 2 | 74d588de2f84a4ef112fd642f7e112a542d5ef11 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 5.09e-04 | 194 | 8 | 2 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 5.09e-04 | 194 | 8 | 2 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 5.09e-04 | 194 | 8 | 2 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 5.09e-04 | 194 | 8 | 2 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.09e-04 | 194 | 8 | 2 | 024568d8a862f0fe4da1f66a58c6e71f0e8279f3 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Resident_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.09e-04 | 194 | 8 | 2 | b73e75f973ddfaa8d7e2adb30dbca14076803603 | |
| ToppCell | medial-2-Hematologic-Myeloid_Dendritic_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.14e-04 | 195 | 8 | 2 | 54a404ee1b97d0659fcffafb20d11f878ed453d4 | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.14e-04 | 195 | 8 | 2 | 35a5302b8b3e76bc92dc38979400c979f0e86550 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.14e-04 | 195 | 8 | 2 | 309c02ab7612687bdae3f12a60ebd4fb5839496e | |
| ToppCell | critical-Myeloid-Resident_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.14e-04 | 195 | 8 | 2 | ed0d281815d351c4a9c96cd87f97d8c524f10f69 | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 5.14e-04 | 195 | 8 | 2 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-04 | 195 | 8 | 2 | 97a9410f47beca02346902d078288a75bfe6e56b | |
| ToppCell | BAL-Control|BAL / Compartment, Disease Groups and Clusters | 5.14e-04 | 195 | 8 | 2 | bf940d836a34118a56bc956e6210e310510bca4d | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.14e-04 | 195 | 8 | 2 | c0d1ecb378bb482a8e08d7065fcca07a65687dac | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.20e-04 | 196 | 8 | 2 | a692cee9254f3771a076b290688a4d0120c02c3b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.20e-04 | 196 | 8 | 2 | e8db58e82300981f981402618a1befb91f6690fd | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.20e-04 | 196 | 8 | 2 | 2cf42b702ea15adfa6bbd86a3c9613271863f86c | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-04 | 197 | 8 | 2 | 7e15ed71881105dee5c7ffc052063ecc8ac0b36e | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.25e-04 | 197 | 8 | 2 | 06cb968c44c1ae689ecce04567d9fbc2beda49b2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-04 | 197 | 8 | 2 | 363ae03310f63a586ba3cea2a59f35d5a335a54e | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-04 | 197 | 8 | 2 | febafd8f0f5bb9a09f496f240e6b6b5e9275669b | |
| ToppCell | distal-1-Hematologic-Myeloid_Dendritic_Type_2|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.30e-04 | 198 | 8 | 2 | 5b27949ac3fc7eb34949f9f360d57e6ae82a2368 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.30e-04 | 198 | 8 | 2 | d73585a5587941483db8d9ddc2d68f7d852bbbc8 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.30e-04 | 198 | 8 | 2 | c08198131d5caff6f488180ca88413682ee5948b | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(50)_cDC2|Sigmoid / shred on region, Cell_type, and subtype | 5.36e-04 | 199 | 8 | 2 | 402af84db90d8a49d67cf44c24766aefb00fd716 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_DC2|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.36e-04 | 199 | 8 | 2 | 829ec877c6c16c4abf8d3d139aea94af599406fe | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 5.36e-04 | 199 | 8 | 2 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_DC2|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.36e-04 | 199 | 8 | 2 | 64b320a9e4e65071cff77980dbff7e06526819b3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 5.36e-04 | 199 | 8 | 2 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | (0)_NK/T_cells-(0)_T_CD4|(0)_NK/T_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.36e-04 | 199 | 8 | 2 | a4bffbb9587829f0f52716d6939315a1aa1ae9b3 | |
| ToppCell | (2)_B_cell-(22)_B_cell_memory|(2)_B_cell / shred on Cell_type and subtype | 5.36e-04 | 199 | 8 | 2 | c4c8faa458c1a49487e13667e68bfb1b4b7759b5 | |
| ToppCell | (5)_Dendritic_cell|World / shred on Cell_type and subtype | 5.36e-04 | 199 | 8 | 2 | 495de74a918c5c625a2d0ef120fe4162d4ce6e76 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC2|Sigmoid / Region, Cell class and subclass | 5.36e-04 | 199 | 8 | 2 | cd74db6db694b68f81dcf9d9342d125d00357ec1 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.36e-04 | 199 | 8 | 2 | d12cee0d776210dc245b0bbef3733d9cb8260dd3 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.41e-04 | 200 | 8 | 2 | 41a206350eff2a196ccc1a36a9636a87c74f6962 | |
| ToppCell | Biopsy_Control_(H.)-Immune-cDCs|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.41e-04 | 200 | 8 | 2 | cc6ba99a877a13c63dc1d6f81538065a7f29b8f6 | |
| ToppCell | Transverse-Dendritic_cell-cDC2|Transverse / Region, Cell class and subclass | 5.41e-04 | 200 | 8 | 2 | 80730a6372627543b84d8fb1b94c481db17c6500 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.41e-04 | 200 | 8 | 2 | 0c199b98f18c1312c56d7571260d849c68ae384c | |
| ToppCell | moderate-Myeloid-Resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.41e-04 | 200 | 8 | 2 | 090ba5885bbd03f4c43025ea3cc1699fae9de314 | |
| ToppCell | Sigmoid-Dendritic_cell|Sigmoid / Region, Cell class and subclass | 5.41e-04 | 200 | 8 | 2 | 994a49317b806d115c630cd90897a91fc85ff467 | |
| ToppCell | Transverse-(5)_Dendritic_cell|Transverse / shred on region, Cell_type, and subtype | 5.41e-04 | 200 | 8 | 2 | 6c32a64f7c38818b93eec1e2d41067e5dbd90541 | |
| ToppCell | Transverse-Dendritic_cell|Transverse / Region, Cell class and subclass | 5.41e-04 | 200 | 8 | 2 | b0e9eaf0e57e53645e272e2cea9f09bfcfe12a9b | |
| ToppCell | Transverse-(5)_Dendritic_cell-(50)_cDC2|Transverse / shred on region, Cell_type, and subtype | 5.41e-04 | 200 | 8 | 2 | eea523f7512b54d7443651bce3ff6d043a9897aa | |
| ToppCell | Sigmoid-(5)_Dendritic_cell|Sigmoid / shred on region, Cell_type, and subtype | 5.41e-04 | 200 | 8 | 2 | 1130328863a4fcfa7dcd7261e9905943057777c5 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Resident_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.41e-04 | 200 | 8 | 2 | cf3ce531ef9ad0e6bba76432b3d226fe5b62e4e8 | |
| ToppCell | Caecum-B_cell-B_cell_memory|B_cell / Region, Cell class and subclass | 5.41e-04 | 200 | 8 | 2 | 1c9ac75961c7008e2680e551cd279941d6eb80be | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 5.41e-04 | 200 | 8 | 2 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 5.41e-04 | 200 | 8 | 2 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| Drug | Patrol | 2.49e-05 | 22 | 8 | 2 | CID000091694 | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 3.46e-05 | 197 | 8 | 3 | 4152_UP | |
| Drug | Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; HL60; HG-U133A | 3.51e-05 | 198 | 8 | 3 | 1756_UP | |
| Drug | dibenzyl-N,N-diethylphosphoramidite | 4.17e-04 | 89 | 8 | 2 | CID005066231 | |
| Drug | DB04780 | 1.51e-03 | 170 | 8 | 2 | CID005459389 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.51e-03 | 170 | 8 | 2 | 3746_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.58e-03 | 174 | 8 | 2 | 1659_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.63e-03 | 177 | 8 | 2 | 3227_DN | |
| Drug | lomustine; Up 200; 100uM; PC3; HT_HG-U133A | 1.65e-03 | 178 | 8 | 2 | 7094_UP | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 1.69e-03 | 180 | 8 | 2 | 2680_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.71e-03 | 181 | 8 | 2 | 7005_DN | |
| Drug | lomustine; Up 200; 100uM; MCF7; HT_HG-U133A | 1.78e-03 | 185 | 8 | 2 | 7045_UP | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.82e-03 | 187 | 8 | 2 | 5294_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; HL60; HT_HG-U133A | 1.84e-03 | 188 | 8 | 2 | 3046_UP | |
| Drug | AC1Q6AQ7 | 1.84e-03 | 188 | 8 | 2 | CID000005515 | |
| Drug | Isotretinoin [4759-48-2]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.88e-03 | 190 | 8 | 2 | 6017_UP | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 5290_UP | |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; HL60; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 2393_UP | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; HL60; HT_HG-U133A | 1.92e-03 | 192 | 8 | 2 | 1847_DN | |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.92e-03 | 192 | 8 | 2 | 6728_UP | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 1.94e-03 | 193 | 8 | 2 | 431_DN | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.94e-03 | 193 | 8 | 2 | 3850_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.94e-03 | 193 | 8 | 2 | 3973_DN | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.94e-03 | 193 | 8 | 2 | 7409_DN | |
| Drug | Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.94e-03 | 193 | 8 | 2 | 2412_UP | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 4828_UP | |
| Drug | semustine; Up 200; 100uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 7487_UP | |
| Drug | (+/-)-thalidomide; Down 200; 100uM; MCF7; HG-U133A | 1.96e-03 | 194 | 8 | 2 | 606_DN | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 4126_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; HL60; HG-U133A | 1.96e-03 | 194 | 8 | 2 | 1585_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 5216_DN | |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 4411_DN | |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 3254_DN | |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; HL60; HG-U133A | 1.98e-03 | 195 | 8 | 2 | 1974_UP | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 2426_UP | |
| Drug | Chlorambucil [305-03-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 3869_UP | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 4393_DN | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 5277_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 1836_DN | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HG-U133A | 1.98e-03 | 195 | 8 | 2 | 1903_UP | |
| Drug | Acemetacin [53164-05-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 2411_UP | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 7353_DN | |
| Drug | Vidarabine [5536-17-4]; Up 200; 15uM; HL60; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2706_UP | |
| Drug | Sulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 5622_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2961_UP | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 3849_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 4120_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; HL60; HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2015_UP | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 3333_DN | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 5704_UP | |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 5668_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2889_DN | |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 4374_DN | |
| Drug | Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2263_UP | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A | 2.02e-03 | 197 | 8 | 2 | 1909_UP | |
| Drug | Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3512_UP | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 5397_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3202_DN | |
| Drug | WY-14643; Up 200; 100uM; PC3; HG-U133A | 2.02e-03 | 197 | 8 | 2 | 464_UP | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 5332_DN | |
| Drug | indomethacin, USP; Down 200; 100uM; SKMEL5; HG-U133A | 2.02e-03 | 197 | 8 | 2 | 503_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 4968_UP | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; HL60; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 2404_UP | |
| Drug | CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6412_DN | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7412_UP | |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 4150_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3277_DN | |
| Drug | sodium 4-phenylbutyrate; Up 200; 100uM; MCF7; HG-U133A | 2.02e-03 | 197 | 8 | 2 | 341_UP | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3877_DN | |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; HL60; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 2161_UP | |
| Drug | butein; Down 200; 10uM; MCF7; HG-U133A | 2.04e-03 | 198 | 8 | 2 | 607_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 6106_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; HL60; HG-U133A | 2.04e-03 | 198 | 8 | 2 | 2005_UP | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 3632_DN | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 6196_UP | |
| Drug | Caffeic acid [3331-39-5]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5352_DN | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 4133_DN | |
| Drug | PF-00539758-00 [351321-34-1]; Down 200; 10uM; PC3; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 6421_DN | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5543_DN | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 7551_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 6455_UP | |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 6777_UP | |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5490_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HG-U133A | 2.04e-03 | 198 | 8 | 2 | 387_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; HL60; HG-U133A | 2.04e-03 | 198 | 8 | 2 | 1748_UP | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 3642_DN | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; PC3; HG-U133A | 2.04e-03 | 198 | 8 | 2 | 1945_UP | |
| Drug | GSK-3 Inhibitor IX; Down 200; 0.5uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 6589_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 3609_DN | |
| Disease | atopic eczema | 1.97e-03 | 252 | 8 | 2 | EFO_0000274 | |
| Disease | alcohol consumption measurement | 3.55e-03 | 1242 | 8 | 3 | EFO_0007878 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 6.04e-03 | 447 | 8 | 2 | EFO_0000694, MONDO_0100096 | |
| Disease | parental longevity | 7.33e-03 | 494 | 8 | 2 | EFO_0007796 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTKPPSQLPGPAKPP | 466 | Q9Y6V0 | |
| KKPAPLPPSSSPGPP | 381 | Q8N3F8 | |
| GPGPSPSPSPSPAKP | 101 | Q96T92 | |
| PPTPPGQPPISPKKF | 961 | Q92835 | |
| PPPKSGPSLVPGKTP | 26 | Q9UJ71 | |
| KPPPISKPPAGPPSS | 821 | Q5W0Q7 | |
| PPGPPGTTPPGQKSP | 1281 | O14924 | |
| TPPSPKGGPATPSPK | 946 | E9PAV3 | |
| PTPPAATPPSPKGGP | 986 | E9PAV3 | |
| TPPSPKGGPATPSPK | 1086 | E9PAV3 | |
| ATPPSPKGGPATPPP | 1246 | E9PAV3 | |
| TPPSPKGSPGTPPPK | 1316 | E9PAV3 | |
| KGSPGTPPPKGAPTP | 1321 | E9PAV3 |